Immunodepletive anti-α/β-TCR antibody in transplantation of composite tissue allografts: Cleveland Clinic research experience

Immunotherapy

Volumn 1, Issue 4, 2009, Pages 585-598

  Siemionow, Maria ^a   Klimczak, Aleksandra ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anti TCR antibody; Antilymphocyte serum; Chimerism; Composite tissue allograft; Face transplant; Limb allograft; Nonselective T cell depletion; Selective T cell depletion; Tolerance

Indexed keywords

CYCLOSPORIN A; FLUOCINOLONE ACETONIDE; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ALPHA BETA T CELL RECEPTOR; MONOCLONAL ANTIBODY R73; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; CARDIAC GRAFT REJECTION; CHIMERA; CLINICAL PROTOCOL; COMPOSITE GRAFT; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FACIAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART GRAFT; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAXILLOFACIAL DISORDER; MAXILLOFACIAL SURGERY; MEMORY T LYMPHOCYTE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN ALLOGRAFT; T CELL DEPLETION; THYMECTOMY;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOMEDICAL RESEARCH; BONE AND BONES; BONE MARROW; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; MODELS, ANIMAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN; TISSUE TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 77953392487     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/IMT.09.34     Document Type: Review

References (14)

1. Siemionow M, Klimczak A: Basics of immune responses in transplantation in preparation for application of composite tissue allografts in plastic and reconstructive surgery: part I. Plast. Reconstr. Surg. 121(1), 4e-12e (2008).
2. Siemionow M, Klimczak A: Tolerance and future directions for composite tissue allograft transplants: part II. Plast. Reconstr. Surg. 123(1), 7e-17e (2009). •• Current knowledge and future perspectives for tolerance induction in composite tissue allografts.
3. Clavijo-Alvarez JA, Hamad GG, Taieb A, Lee WP: Pharmacologic approaches to composite tissue allograft. J. Hand Surg. [Am] 32(1), 104-118 (2007).
4. Bos JD, Kapsenberg ML: The skin immune system: progress in cutaneous biology. Immunol. Today 14(2), 75-78 (1993).
5. Mathes DW, Randolph MA, Solari MG et al.: Split tolerance to a composite tissue allograft in a swine model. Transplantation 75(1), 25-31 (2003).
6. Wang J, Dong Y, Sun JZ et al.: Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation. Am. J. Transplant. 6(11), 2563-2571 (2006).
7. Murase N, Starzl TE, Tanabe M et al.: Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation 60(2), 158-171 (1995).
8. Starzl TE, Demetris AJ, Murase N et al.: Cell migration, chimerism, and graft acceptance. Lancet 339 (8809), 1579-1582 (1992).
9. Starzl TE, Zinkernagel RM: Antigen localization and migration in immunity and tolerance. N. Engl. J. Med. 339(26), 1905-1913 (1998).
10. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172(4379), 603-606 (1953).
11. Kim SK, Aziz S, Oyer P, Hentz VR: Use of cyclosporin A in allotransplantation of rat limbs. Ann. Plast. Surg. 12(3), 249-255 (1984).
12. Kanaya K, Tsuchida Y, Inobe M et al.: Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation 75(3), 275-281 (2003). (Pubitemid 36222949)
13. Foster RD, Pham S, Li S, Aitouche A: Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 76(6), 988-994 (2003). (Pubitemid 37186033)
14. Foster RD, Liu T: Orthotopic hindlimb transplantation in the mouse. J. Reconstr. Microsurg. 19(1), 49-52; discussion 53-144 (2003).